| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.006 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.007 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.008 |